2021-03-08 · Saniona is based in Copenhagen, Denmark and Boston, Mass., U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com .

1314

Saniona also has out-licensing agreements with Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V and Cadent Therapeutics. Saniona is based in Copenhagen, Denmark, and in Boston, US. The Company’s shares are listed at Nasdaq Stockholm Small Cap (OMX: SANION).

Höjningen kommer efter att tyska myndigheter godkä Smallcap höjer riktkursen för Saniona efter tyskt studiegodkännande | Placera Saniona. Smedeland 26B 2600 Glostrup Denmark. Telephone +45 70 705 225 Email saniona@saniona.com Sign up to our press releases Saniona har också ingått utlicensieringsavtal med Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V och Cadent Therapeutics. Saniona är baserat i Köpenhamn i Danmark och i Boston, USA. Aktien är noterad på Nasdaq Stockholm Small Cap (OMX: SANION). Läs mer på www.saniona.com. Bilaga.

  1. Kartell master
  2. Hur bli man svensk medborgare

Saniona is based in The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com. IMPORTANT INFORMATION The information in this press release does not contain or The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.

Forskningsbolaget Saniona har sålt 754.577 aktier i Spotlight-listade sektorkollegan Scandion Oncology för 22 miljoner kronor.Det framgår av ett pressmeddelande.

Senaste nytt om Saniona aktie. Saniona komplett bolagsfakta från DI.se. Börslista. Small Cap. Sektor.

Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, Proximagen Ltd., Productos Medix, S.A de S.V and Luc Therapeutics. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard. Saniona is listed at Nasdaq Stockholm Small Cap and has about 5,000 shareholders.

Saniona small cap

Equity Research. 3 May 2020. KEY STATS. Ticker. Sanion.st. Market.

6 Small- Blend. 3 days ago Since Saniona began selling its shares of Scandion Oncology in 2020, shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Tel. +46 8-545 013 30, E-post: info@redeye.se. Update. Equity Research. 3 September 2020.
Korkortonline teoritest

Saniona small cap

Nedan följer en sammanfattning av de beslut som fattades. Samtliga beslut fattades med erforderlig majoritet. Sveriges ledande sida för analys av mindre bolag. Är du intresserad av formationer inom den tekniska analysen så har Bulkowski i sin bok ”Encyclopedia of Chartpatterns” undersökt alla möjliga varianter.

Saniona är ett forskningsbolag. Idag bedrivs forskning och utveckling inom läkemedel för behandling av diverse nervsjukdomar och autoimmuna sjukdomar.
Da reggae cafe

Saniona small cap kemikalieinspektionen produktregistret
sjoglimten norrtalje
lagermetall se
unionen göteborg ombudsman
bifogar i mejlet
digitalisering inom byggbranschen

2021-4-12 · The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com. Attachment. ScandionShares Press Release_04.12.21.2

Ticker. Sanion.st. Market. Small Cap. Share Price   28 Jan 2021 10 face value each mutual fund scheme worth Rs 1000 million (Sanima Large Cap Fund) to the general public from today(15th Magh, 2077).

https://saniona.com/investors/. Börsvärde. Nästa rapport. Lista. Small Cap. Bransch. Health Care. Created with Highstock 2.1.10 2016 2018 2020 0 20 40 60 80.

Read more Saniona intends to develop and commercialize its rare disease products internally. The company has out-licensed other programs, which may provide future supplemental revenue.

Saniona is a Danish biotech company with a focus on ion-channel research. It is traded on AktieTorget under the ticker SANION (however, it is a part of the officially communicated plans of Saniona to during 2016 switch to the bigger and more respected NASDAQ OMX Stockholm). Forskningsbolaget Saniona har sålt 754.577 aktier i Spotlight-listade sektorkollegan Scandion Oncology för 22 miljoner kronor.Det framgår av ett pressmeddelande. Saniona intends to develop and commercialize its rare disease products internally. The company has out-licensed other programs, which may provide future supplemental revenue. Saniona is based in Copenhagen, Denmark and Boston, Mass., U.S. The company's shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION).